Pharmexcil suspends Maiden pharma’s membership

In the wake of the ongoing WHO probe against the Haryana-based Maiden Pharmaceuticals whose cough syrups are under the scanner following the death of 66 kids in the Gambia after they allegedly consumed it, the Pharmaceuticals Export Promotion Council of India (Pharmexcil) has suspended its membership. The suspension means that the company’s exports will become ineligible for incentives under the Market Access Initiative Scheme.

The suspension came after the council warned the firm of suspension of its authorization certificate if it failed to share details of its licensees and importers with Pharmexcil by October 7.

“The council is not in receipt of any inputs/report on the adverse events and hereby state that the membership of Maiden Pharmaceuticals with Pharmexcil… is suspended with immediate effect,” the council said in a letter dated October 7, to the company. Daily Pioneer